NDC 68788-4064 – Terazosin

Terazosin Hydrochloride 2 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC68788-4064

Product details

Brand name
Terazosin
Generic name
Terazosin
Labeler
Preferred Pharmaceuticals Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075667
Marketed since
January 28, 2026
Listing expires
December 31, 2027
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (2)

Package NDCDescriptionSince
68788-4064-1100 CAPSULE in 1 BOTTLE (68788-4064-1)Jan 28, 2026
68788-4064-330 CAPSULE in 1 BOTTLE (68788-4064-3)Jan 28, 2026

Other Terazosin products